Terkko Navigator / Haahtela, T(ari)*

Potential Interplay between Nrf2, TRPA1, and TRPV1 in Nutrients for the Control of COVID-19

Allergy-Related Symptoms Are Poorly Predicted by IgE and Skin Prick Testing in Early Life

Efficacy of broccoli and glucoraphanin in COVID-19: From hypothesis to proof-of-concept with three experimental clinical cases

Spices to Control COVID-19 Symptoms: Yes, but Not Only…

Shared DNA methylation signatures in childhood allergy: The MeDALL study

A call for urgent action to safeguard our planet and our health in line with the helsinki declaration

Treatment of allergic rhinitis during and outside the pollen season using mobile technology. A MASK study

Nrf2-interacting nutrients and COVID-19: time for research to develop adaptation strategies

Correction to: Vilnius Declaration on chronic respiratory diseases: multisectoral care pathways embedding guided self-management, mHealth and air pollution in chronic respiratory diseases

The Helsinki Declaration 2020: Europe that protects

Correction to: Is diet partly responsible for differences in COVID-19 death rates between and within countries?

Immune-microbiota interaction in Finnish and Russian Karelia young people with high and low allergy prevalence

Long-term trends of asthma, allergic rhinitis and atopic eczema in young Finnish men: a retrospective analysis, 1926-2017

Cabbage and fermented vegetables: From death rate heterogeneity in countries to candidates for mitigation strategies of severe COVID-19

Fast and slow health crises of Homo urbanicus: loss of resilience in communicable diseases, like COVID-19, and non-communicable diseases

ARIA-EAACI statement on asthma and COVID-19 (June 2, 2020)

Digital transformation of health and care to sustain Planetary Health: The MASK proof-of-concept for airway diseases-POLLAR symposium under the auspices of Finland's Presidency of the EU, 2019 and MACVIA-France, Global Alliance against Chronic Respir

ARIA digital anamorphosis: Digital transformation of health and care in airway diseases from research to practice

Is diet partly responsible for differences in COVID-19 death rates between and within countries?

Minimising the environmental impact of inhaled therapies

Managing Allergic Rhinitis in the Pharmacy: An ARIA Guide for Implementation in Practice

Handling of allergen immunotherapy in the COVID-19 pandemic: An ARIA-EAACI statement

Intranasal corticosteroids in allergic rhinitis in COVID-19 infected patients: An ARIA-EAACI statement

IgE allergy diagnostics and other relevant tests in allergy, a World Allergy Organization position paper

Contrasting microbiotas between Finnish and Estonian infants: Exposure to Acinetobacter may contribute to the allergy gap

Healthy people in healthy premises: the Finnish Indoor Air and Health Programme 2018-2028

From ARIA guidelines to the digital transformation of health in rhinitis and asthma multimorbidity

Helsinki by nature: The Nature Step to Respiratory Health

School environment associates with lung function and autonomic nervous system activity in children: a cross-sectional study

Next-generation Allergic Rhinitis and Its Impact on Asthma (ARIA) guidelines for allergic rhinitis based on Grading of Recommendations Assessment, Development and Evaluation (GRADE) and real-world evidence

Next-generation ARIA care pathways for rhinitis and asthma: a model for multimorbid chronic diseases

Mobile Technology in Allergic Rhinitis: Evolution in Management or Revolution in Health and Care?

The increase of asthma prevalence has levelled off and symptoms decreased in adults during 20 years from 1996 to 2016 in Helsinki, Finland

ARIA masterclass 2018: From guidelines to real-life implementation

25 years of respiratory health in Finland

Multimorbidity in Asthma, Allergic Conditions and COPD Increase Disease Severity, Drug Use and Costs: The Finnish Pharmacy Survey

2019 ARIA Care pathways for allergen immunotherapy

Mobile technology offers novel insights into the control and treatment of allergic rhinitis: The MASK study

Guidance to 2018 good practice: ARIA digitally-enabled, integrated, person-centred care for rhinitis and asthma

A biodiversity hypothesis

House dust microbiome and human health risks

Birch pollen allergen immunotherapy reprograms nasal epithelial transcriptome and recovers microbial diversity

Vilnius Declaration on chronic respiratory diseases: multisectoral care pathways embedding guided self-management, mHealth and air pollution in chronic respiratory diseases

Adherence to treatment in allergic rhinitis using mobile technology. The MASK Study

ARIA pharmacy 2018 "Allergic rhinitis care pathways for community pharmacy": AIRWAYS ICPs initiative (European Innovation Partnership on Active and Healthy Ageing, DG CONNECT and DG Santé) POLLAR (Impact of Air POLLution on Asthma and Rhinitis) GARD

MASK 2017: ARIA digitally-enabled, integrated, person-centred care for rhinitis and asthma multimorbidity using real-world-evidence

Allergic Rhinitis and its Impact on Asthma (ARIA) Phase 4 (2018): Change management in allergic rhinitis and asthma multimorbidity using mobile technology

A strategy for measuring health outcomes and evaluating impacts of interventions on asthma and COPD-common chronic respiratory diseases in Global Alliance against Chronic Respiratory Diseases (GARD) countries

Dietary patterns and respiratory health in adults from nine European countries-Evidence from the GA² LEN study

Potential Interplay between Nrf2, TRPA1, and TRPV1 in Nutrients for the Control of COVID-19.